Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis

Reza Bayat Mokhtari(Hospital for Sick Children), Herman Yeger(Hospital for Sick Children)
Oncotarget
July 1, 2021
Cited by 23


Related Papers